Member Info for Laura2022

Theyve dropped advertised bid to 1.5p but its 1.63p to sell !!

Outrageous games

Daylight robbery

Can anything stop them before nexr week ?

May 2025

Obstructive lung diseases like asthma and COPD affect over 42 million people in the United States and more than 500 million worldwide, placing a major burden on global respiratory health [2]. Yet common imaging techniques currently used often lack the detail to show how these conditions affect lung function. There is a clear unmet need for safe, accurate, and non-invasive imaging tools to visualize lung ventilation without radiation exposure. This is particularly urgent in pediatrics, where repeat imaging is often necessary to track disease progression or treatment response. 

Philips and Polarean are addressing this need by bringing advanced, non-invasive Xenon MRI into routine practice and increasing access to younger patients. 

And in recent RNS POLX now presnet in over 25% of USA States

Negotiated and produced over $2.7B annually through the National Group Purchasing

Would imagine news next week and as an aside the charts are very oversold due to the china/us ease plus traders gone elsewhere, think FOMO will hit soon , I intend to add more today

Anyone know where his posts are ,they all say posts not found on LSE and i wanted some old research of his from summer

Tia

The Company news to update on the situation, silence is not helping

Still watching

https://www.bbc.co.uk/news/articles/c20e2lnvgpgo

Trench

I assume you're replying to one of the green box obsessive, not quite sure why they still post here

This was was said in the presentation late Sept

Have applied for other grants and will announce if/when progressed

Conversion rate 2022-2024 was 27%

Conversation rate 2025 jumped to 45%

6 late stage contracts due

Also Mr P

It was merely a "consideration " not a plan

Expect more delayed trades

The double standards here is almost as bad as on the REE /Altona board

Apologies

But you hopefully get the point

Mathematical explanation:

Altona Market Cap = £6.13m or US$8.04m

Altona Contained TREO (tonnes) = 330,000

Market Cap / TREO (US$/tonne)

8,040,000 / 330,000

= US$24.36

............

So that's Altona valued at US$24.36 per tonne contained (in ground) rare earths, compared to Pensana at US$122 using the same formula.

So Pensana's contained TREO is valued at 5 times more than Altona's per tonne rare earths.

Then you have the added value of the Flourspar prospect for Altona, so showing a large value disconnect in my eyes.

Rnf

IBAI and PYC the only 2 A.I specialist bio techs on AIM

Unique

Funding mentioned August 2025 should be any time now

So oversold now , thankfully my average is low

Surely camt go much lower and bad news priced in ?

Thought ?

One of major shareholders (braco) have €1.7bln turnover

Charts most over sold in 3yrs, large holders in control

Even with cash burn they still have c $5mln cash as of Nov 2025

They have 6-9mth runway till end Q22026 at least

They have won 3 orders in last 2mths

I can see Philpps or medical imaging company making an offer

Mgmt won't get 75% backing for this "proposal '

Cash and cash equivalents of US$7.3m as at 30 June 2025

Mister rpostive

I totally agree

Like a few games players last week or so

Filter button useful

Maven capital jas been a drag on the share price for the 3 weeks since the RNS from PKLX

Indont believe that the market makers have taken this on without having a buyer ( the consistent block buyer and off market transactions after hours )

Thats Maven out in my voew

They had 2.7% left and that single trade is about 1.3% ( plus all the other large sells between now and their TR1 previously